These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5980830)

  • 21. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins.
    Welsch CW
    Cancer Res; 1985 Aug; 45(8):3415-43. PubMed ID: 3926298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
    Saarinen NM; Wärri A; Dings RP; Airio M; Smeds AI; Mäkelä S
    Int J Cancer; 2008 Sep; 123(5):1196-204. PubMed ID: 18528864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of podophyllic acid on malignant tumors. II. Effects of podophyllic acid ethyl hydrazide on the incorporation of precursors into the nucleic acids of mouse mammary tumors and livers in vivo.
    Georgatsos JG; Karemfyllis T
    Biochem Pharmacol; 1968 Aug; 17(8):1489-92. PubMed ID: 5672811
    [No Abstract]   [Full Text] [Related]  

  • 24. Altered uterine sensitivity to oxytocin and prostaglandin F2 alpha in dimethylbenz(a)anthracene (DMBA)-induced rat mammary carcinoma: the effects of tamoxifen and/or recombinant human interferon alpha 2b therapy.
    Badary OA; Agha AM; el-Sayed ES; Hamada FM
    Pharmacol Res; 1996; 34(3-4):99-103. PubMed ID: 9051698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of medroxyprogesterone acetate on DMBA-induced rat mammary carcinoma and on immunological reactivity.
    Spreafico F; Filippeschi S; Malfiore C; Noseda S; Falautano P; Serraglia N
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):45-51. PubMed ID: 6211360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary and mammary tumors due to hydrazine sulfate in BALB-c-CbSe forced breeder and pseudopregnant mice].
    Biancifiori C
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1971; 31(3):79-90. PubMed ID: 5170159
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE METABOLISM OF A CYTOSTATIC METHYLHYDRAZINE DERIVATIVE (NATULAN)].
    RAAFLAUB J; SCHWARTZ DE
    Experientia; 1965 Jan; 21():44-5. PubMed ID: 14283528
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement and inhibition of mammary tumor formation and growth by cytostatic drugs.
    Medina D; Shepherd F
    Cancer Res; 1977 Oct; 37(10):3571-7. PubMed ID: 908008
    [No Abstract]   [Full Text] [Related]  

  • 29. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of mammary gland DNA synthesis on carcinogen-induced mammary tumorigenesis in rats.
    Nagasawa H; Yanai R; Taniguchi H
    Cancer Res; 1976 Jul; 36(7 PT 1):2223-6. PubMed ID: 945123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines.
    Shyam K; Penketh PG; Shapiro M; Belcourt MF; Loomis RH; Rockwell S; Sartorelli AC
    J Med Chem; 1999 Mar; 42(5):941-6. PubMed ID: 10072691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells.
    Mousavi E; Tavakolfar S; Almasirad A; Kooshafar Z; Dehghani S; Afsharinasab A; Amanzadeh A; Shafiee S; Salimi M
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1195-1203. PubMed ID: 28451832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of tumors in rats with procarbazine hydrochloride.
    Kelly MG; O'Gara RW; Yancey ST; Botkin C
    J Natl Cancer Inst; 1968 May; 40(5):1027-51. PubMed ID: 5648132
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapeutic response of 3-methylcholanthrene-induced mammary carcinoma in Wistar rats to 51 agents.
    Gropper L; Gruenstein M; Shimkin MB
    Cancer Res; 1967 Nov; 27(11 Pt 2):1289-97. PubMed ID: 6073513
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P; Berger MR; Unger C; Eibl H
    Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure.
    Wattenberg LW; Coccia JB; Galbraith AR
    Cancer Lett; 1994 Aug; 83(1-2):165-9. PubMed ID: 8062211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of mammary cell division in relation to age: its significance in the induction of mammary tumors by carcinogen in rats.
    Nagasawa H; Yanai R
    J Natl Cancer Inst; 1974 Feb; 52(2):609-10. PubMed ID: 4816015
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemically induced autochthonous tumor models in experimental chemotherapy.
    Zeller WJ; Berger MR
    Behring Inst Mitt; 1984 May; (74):201-8. PubMed ID: 6477353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cytogenetic footprint for mammary carcinomas induced by PhIP in rats.
    Christian AT
    Toxicology; 2002 Dec; 181-182():95-7. PubMed ID: 12505291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary clinical studies with ibenzmethyzin.
    DeVita VT; Serpick A; Carbone PP
    Clin Pharmacol Ther; 1966; 7(4):542-6. PubMed ID: 5939977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.